- Home
- LRMR vs RIV Comparison
LRMR vs RIV Comparison
Compare LRMR & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- RIV
- Stock Information
- Founded
- LRMR N/A
- RIV 2015
- Country
- LRMR United States
- RIV United States
- Employees
- LRMR N/A
- RIV N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- RIV Finance Companies
- Sector
- LRMR Health Care
- RIV Finance
- Exchange
- LRMR Nasdaq
- RIV Nasdaq
- Market Cap
- LRMR 309.8M
- RIV 266.0M
- IPO Year
- LRMR N/A
- RIV N/A
- Fundamental
- Price
- LRMR $3.89
- RIV $12.43
- Analyst Decision
- LRMR Strong Buy
- RIV
- Analyst Count
- LRMR 8
- RIV 0
- Target Price
- LRMR $17.88
- RIV N/A
- AVG Volume (30 Days)
- LRMR 1.4M
- RIV 87.6K
- Earning Date
- LRMR 10-29-2025
- RIV 01-01-0001
- Dividend Yield
- LRMR N/A
- RIV 12.85%
- EPS Growth
- LRMR N/A
- RIV N/A
- EPS
- LRMR N/A
- RIV N/A
- Revenue
- LRMR N/A
- RIV N/A
- Revenue This Year
- LRMR N/A
- RIV N/A
- Revenue Next Year
- LRMR N/A
- RIV N/A
- P/E Ratio
- LRMR N/A
- RIV N/A
- Revenue Growth
- LRMR N/A
- RIV N/A
- 52 Week Low
- LRMR $1.61
- RIV $9.63
- 52 Week High
- LRMR $9.50
- RIV $12.43
- Technical
- Relative Strength Index (RSI)
- LRMR 54.32
- RIV 54.47
- Support Level
- LRMR $3.59
- RIV $12.40
- Resistance Level
- LRMR $4.08
- RIV $12.56
- Average True Range (ATR)
- LRMR 0.28
- RIV 0.10
- MACD
- LRMR -0.01
- RIV -0.00
- Stochastic Oscillator
- LRMR 58.33
- RIV 52.25
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.